JF
CRSP icon

Jump Financial’s CRISPR Therapeutics CRSP Stock Holding History

Jump Financial’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
277,952
+170,513
+159% +$8.99M 0.12% 177
2026
Q1 		$5.11M Buy
107,439
+100,961
+1,559% +$5.33M 0.07% 355
2025
Q4 		$340K Buy
+6,478
New +$388K ﹤0.01% 1486
2025
Q3 		– Sell
-356,306
Closed -$17.3M – 1859
2025
Q2 		$17.3M Buy
+356,306
New +$13.8M 0.19% 120
2025
Q1 		– Sell
-139,280
Closed -$5.48M – 1652
2024
Q4 		$5.48M Buy
139,280
+88,448
+174% +$4.18M 0.11% 232
2024
Q3 		$2.39M Buy
+50,832
New +$2.58M 0.05% 448
2024
Q1 		– Sell
-42,417
Closed -$2.66M – 1956
2023
Q4 		$2.66M Buy
42,417
+9,110
+27% +$504K 0.08% 287
2023
Q3 		$1.51M Buy
33,307
+22,006
+195% +$1.14M 0.06% 481
2023
Q2 		$634K Sell
11,301
-111,258
-91% -$6.31M 0.02% 911
2023
Q1 		$5.54M Buy
122,559
+67,372
+122% +$3.27M 0.23% 133
2022
Q4 		$2.24M Buy
+55,187
New +$2.93M 0.12% 239
2022
Q2 		– Sell
-6,343
Closed -$398K – 1682
2022
Q1 		$398K Buy
+6,343
New +$398K 0.02% 920
2021
Q4 		– Sell
-2,865
Closed -$320K – 1437
2021
Q3 		$320K Buy
+2,865
New +$360K 0.02% 634
2021
Q2 		– Sell
-5,300
Closed -$646K – 1132
2021
Q1 		$646K Buy
+5,300
New +$800K 0.06% 342

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jump Financial's CRSP Position: Q2 2026 in Review

Jump Financial increased its CRISPR Therapeutics (CRSP) stake by 159% in Q2 2026, buying an estimated $8.99M and bringing the position to 277,952 shares worth $15.2M. The position accounts for 0.12% of the portfolio, ranked #177.

Jump Financial first reported a position in CRSP in Q1 2021 and has held it in 14 quarters since. The position peaked at $17.3M in Q2 2025. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Jump Financial held 277,952 shares of CRISPR Therapeutics worth $15.2M as of Q2 2026.
  • Jump Financial bought 170,513 CRISPR Therapeutics shares in Q2 2026, an estimated $8.99M.
  • CRISPR Therapeutics made up 0.12% of Jump Financial's portfolio in Q2 2026, its #177 holding.
  • Jump Financial first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 14 quarters since.
  • Jump Financial's CRISPR Therapeutics position peaked at $17.3M in Q2 2025.
  • 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.